Allergan plc (NYSE: AGN) revealed that the FDA has accorded its approval to market JUVÉDERM VOLBELLA XC, for use in the lips for lip augmentation and for correction of perioral rhytids, commonly ...

Please provide your email address to receive an email when new articles are posted on . Allergan announced it has received FDA approval to market Juvederm Ultra XC for injection into the lips and ...

The FINANCIAL — Allergan plc, on June 1 announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLBELLA XC, for use in the lips for lip ...

First and Only Filler Approved for Lip Augmentation that Lasts Up to One Year DUBLIN, Oct. 1, 2015 /PRNewswire/ -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced ...

Good news for Kylie Jenner! Juvederm Ultra XC has received FDA approval for lip augmentation, it was announced on October 1 -- and it adds fullness to lips for up to one year! Juvederm has been on the ...

Allergan (makers of Botox, Juvederm, Juvederm Voluma) has added the newest filler to their expanding U.S. aesthetic profile: JUVÉDERM VOLBELLA® XC. JUVÉDERM VOLBELLA® XC was approved by the FDA today ...

Allergan extends its "Juvederm It" campaign with a specialty focus on lips, looking to attract millennials who tend to use fillers before neurotoxins such as Botox. (DDB New York) It’s all about the ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved marketing of Juvéderm Volbella XC for lip augmentation and correcting perioral rhytids in ...

IRVINE, CA--(Marketwired - Feb 15, 2017) - Lip enhancement has become a popular treatment among many celebrities and the public. To keep up with demand, Irvine facial plastic surgeon Ali Sepehr, MD ...

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVEDERM ® ULTRA ...

As Millennials age – remember, the oldest Millennials are in their late 30s – they’re grappling with the same signs of aging as every other generation. Juvederm is tapping into trends of ...

Allergan plc AGN revealed that the FDA has accorded its approval to market JUVÉDERM VOLBELLA XC, for use in the lips for lip augmentation and for correction of perioral rhytids, commonly referred to ...